Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis

ClinicalTrials.gov ID: NCT00321737

Public ClinicalTrials.gov record NCT00321737. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 21, 2026, 8:48 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study to Evaluate the Safety and Efficacy of TAK-390MR (30 mg QD and 60 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the ability of once-daily (QD) treatment with dexlansoprazole modified release (MR) 30 mg and 60 mg or placebo in maintaining healing of erosive esophagitis (EE).

Study identification

NCT ID: NCT00321737
Recruitment status: Completed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Takeda; Industry
Enrollment: 445 participants

Conditions and interventions

Conditions

Interventions

Dexlansoprazole MR Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 2006 (Type not available)
Primary completion: May 2007 (Actual)
Completion: May 2007 (Actual)
Last update posted: Feb 3, 2012

2006 – 2007

United States locations

U.S. sites: 80
U.S. states: 32
U.S. cities: 80

Facility	City	State	ZIP	Site status
Not listed	Huntsville	Alabama	—	—
Not listed	Tuscon	Arizona	—	—
Not listed	Anaheim	California	—	—
Not listed	Azusa	California	—	—
Not listed	Carmichael	California	—	—
Not listed	Chula Vista	California	—	—
Not listed	Cypress	California	—	—
Not listed	Fresno	California	—	—
Not listed	Garden Grove	California	—	—
Not listed	Harrisburg	California	—	—
Not listed	Irvine	California	—	—
Not listed	Lancaster	California	—	—
Not listed	Mission Hills	California	—	—
Not listed	Oakland	California	—	—
Not listed	Orange	California	—	—
Not listed	Pasadena	California	—	—
Not listed	San Diego	California	—	—
Not listed	San Luis Obispo	California	—	—
Not listed	Boulder	Colorado	—	—
Not listed	Colorado Springs	Colorado	—	—
Not listed	Wheat Ridge	Colorado	—	—
Not listed	Boynton Beach	Florida	—	—
Not listed	Jupiter	Florida	—	—
Not listed	Miami	Florida	—	—
Not listed	New Smyma Beach	Florida	—	—
Not listed	Ocala	Florida	—	—
Not listed	St. Petersburg	Florida	—	—
Not listed	Zephyrhills	Florida	—	—
Not listed	Atlanta	Georgia	—	—
Not listed	Honolulu	Hawaii	—	—
Not listed	Boise	Idaho	—	—
Not listed	Moline	Illinois	—	—
Not listed	Oak Forrest	Illinois	—	—
Not listed	Rockford	Illinois	—	—
Not listed	Clive	Iowa	—	—
Not listed	Lexington	Kentucky	—	—
Not listed	Baton Rouge	Louisiana	—	—
Not listed	Metairie	Louisiana	—	—
Not listed	Chevy Chase	Maryland	—	—
Not listed	Hollywood	Maryland	—	—
Not listed	Lutherville	Maryland	—	—
Not listed	Prince Federick	Maryland	—	—
Not listed	Chaska	Minnesota	—	—
Not listed	Jackson	Mississippi	—	—
Not listed	Jefferson City	Missouri	—	—
Not listed	Washington	Missouri	—	—
Not listed	Egg Harbor	New Jersey	—	—
Not listed	Albuquerque	New Mexico	—	—
Not listed	Binghamton	New York	—	—
Not listed	Rochester	New York	—	—
Not listed	Greensboro	North Carolina	—	—
Not listed	High Point	North Carolina	—	—
Not listed	Raleigh	North Carolina	—	—
Not listed	Bismarck	North Dakota	—	—
Not listed	Dayton	Ohio	—	—
Not listed	Mogadore	Ohio	—	—
Not listed	Oklahoma City	Oklahoma	—	—
Not listed	Medford	Oregon	—	—
Not listed	Portland	Oregon	—	—
Not listed	Duncansville	Pennsylvania	—	—
Not listed	Lansdale	Pennsylvania	—	—
Not listed	Anderson	South Carolina	—	—
Not listed	Mt. Pleasant	South Carolina	—	—
Not listed	Bristol	Tennessee	—	—
Not listed	Chattanooga	Tennessee	—	—
Not listed	Germantown	Tennessee	—	—
Not listed	Jackson	Tennessee	—	—
Not listed	Kingsport	Tennessee	—	—
Not listed	Nashville	Tennessee	—	—
Not listed	Amarillo	Texas	—	—
Not listed	Fort Worth	Texas	—	—
Not listed	Houston	Texas	—	—
Not listed	San Antonio	Texas	—	—
Not listed	Ogden	Utah	—	—
Not listed	Charlottesville	Virginia	—	—
Not listed	Chesapeake	Virginia	—	—
Not listed	Spokane	Washington	—	—
Not listed	Tacoma	Washington	—	—
Not listed	Milwaukee	Wisconsin	—	—
Not listed	Monroe	Wisconsin	—	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00321737, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 3, 2012 · Synced Oct 21, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00321737 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →